GSK to buy US cancer biotech Nuvalent for $10.6bn

2 months ago 34
ARTICLE AD BOX
New chief Luke Miels makes his mark at GSK with one of UK drugmakers’ biggest deals
Read Entire Article
  1. Homepage
  2. Latest News
  3. GSK to buy US cancer biotech Nuvalent for $10.6bn

Related

Governments’ borrowing costs hit further multi-decade highs ...

3 hours ago 4

Wetherspoons bans customers playing music from phones in pub...

3 hours ago 3

Redistricting scrambles Florida primary as Alaska awaits Dan...

3 hours ago 2

Trending

Popular

foreignaffairs - Europe Needs a New Way to Cooperate

1 year ago 1024

ft - Mission impossible? Abel faces tricky task leading Berkshire...

1 year ago 1018

pewresearch - Methodology

1 year ago 962

csmonitor - Hiring is up, GDP is down: Economy sends mixed signals as ta...

1 year ago 961

newsnationnow - PBS CEO: New children's programming will 'skid to a halt' un...

1 year ago 872
English (US) English (US) ·
About Us · Terms & Conditions ·

© Crazysimon 2026. All rights are reserved